Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe

Go back to Monopar Expands Phase 2b/3 VOICE Clinical Trial to Europe
(NASDAQ: MNPR) Delayed: 70.54 -0.11 (0.16%)
Previous Close $70.65    52 Week High $ 
Open $71.01    52 Week Low $ 
Day High $71.85    P/E N/A 
Day Low $69.34    EPS $ 
Volume 83,100